Genetic variants in ANCA-associated vasculitis: A meta-analysis

Annals of the Rheumatic Diseases

Volumn 75, Issue 9, 2016, Pages 1687-1692

  Rahmattulla, Chinar ^a   Mooyaart, Antien L ^a   Van Hooven, Daphne ^a   Schoones, Jan W ^a   Bruijn, Jan A ^a   Dekkers, Olaf M ^a,b   Bajema, Ingeborg M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Autoimmune Diseases; Gene Polymorphism; Granulomatosis with polyangiitis; Systemic vasculitis

Indexed keywords

ALPHA 1 ANTITRYPSIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA B ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERFERON REGULATORY FACTOR 5; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; STAT4 PROTEIN; TOLL LIKE RECEPTOR 9; DNA BINDING PROTEIN; HLA ANTIGEN CLASS 1;

ANCA ASSOCIATED VASCULITIS; ARTICLE; CD226 GENE; CTLA 4 GENE; FCGR2A GENE; GENE; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HLA B GENE; HLA DP GENE; HLA DQ GENE; HLA DR GENE; HSD17B8 GENE; HUMAN; INFLAMMATION; IRF5 GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROSCOPIC POLYANGIITIS; PATHOGENESIS; PRIORITY JOURNAL; PTPN22 GENE; RING1 GENE; RXRB GENE; SERPINA1 GENE; STAT4 GENE; SYSTEMATIC REVIEW; TLR9 GENE; WEGENER GRANULOMATOSIS; CASE CONTROL STUDY; GENETIC VARIATION; GENETICS; META ANALYSIS;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX;

EID: 84985930627     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-207601     Document Type: Article

References (44)

1. Berden A, Goceroglu A, Jayne D, et al. Diagnosis and management of ANCA associated vasculitis. BMJ 2012;344:e26.
2. Sable-Fourtassou R, Cohen P, Mahr A, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005;143:632-8.
3. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998;53:743-53.
4. Mukhtyar C, Flossmann O, Hellmich B, et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 2008;67:1004-10.
5. Hogan SL, Falk RJ, Nachman PH, et al. Various forms of life in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Intern Med 2006;144:377-8; author reply 8-9.
6. Hoffman GS, Langford CA. Are there different forms of life in the antineutrophil cytoplasmic antibody universe? Ann Intern Med 2005;143:683-5.
7. Linder R, Orth I, Hagen EC, et al. Differentiation between Wegener's granulomatosis and microscopic polyangiitis by an artificial neural network and by traditional methods. J Rheumatol 2011;38:1039-47.
8. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36-44.
9. Jones RB, Tervaert JW, Hauser T, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010;363:211-20.
10. Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010;363:221-32.
11. Monach PA, Merkel PA. Genetics of vasculitis. Curr Opin Rheumatol 2010;22:157-63.
12. de Lind van Wijngaarden RA, van Rijn L, Hagen EC, et al. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. Clin J Am Soc Nephrol 2008;3:237-52.
13. Piram M, Maldini C, Mahr A. Effect of race/ethnicity on risk, presentation and course of connective tissue diseases and primary systemic vasculitides. Curr Opin Rheumatol 2012;24:193-200.
14. Knight A, Sandin S, Askling J. Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease. Arthritis Rheum 2008;58:302-7.
15. Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012;367:214-23.
16. Xie G, Roshandel D, Sherva R, et al. Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1z.ast;04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum 2013;65:2457-68.
17. Ioannidis JP, Ntzani EE, Trikalinos TA, et al. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.
18. Wacholder S, Chanock S, Garcia-Closas M, et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.
19. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
20. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
21. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007;66:222-7.
22. Tsuchiya N, Kobayashi S, Kawasaki A, et al. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1∗0901 with microscopic polyangiitis. J Rheumatol 2003;30:1534-40.
23. Wieczorek S, Holle JU, Bremer JP, et al. Contrasting association of a non-synonymous leptin receptor gene polymorphism with Wegener's granulomatosis and Churg-Strauss syndrome. Rheumatology (Oxford) 2010;49:907-14.
24. Husmann CA, Holle JU, Moosig F, et al. Genetics of toll like receptor 9 in ANCA associated vasculitides. Ann Rheum Dis 2014;73:890-6.
25. Borenstein M, Hedges LV, Higgins JTH, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 2010;1:97-111.
26. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
27. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
28. Kurreeman F, Liao K, Chibnik L, et al. Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records. Am J Hum Genet 2011;88:57-69.
29. Stahl EA, Raychaudhuri S, Remmers EF, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010;42:508-14.
30. Barrett JC, Clayton DG, Concannon P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-7.
31. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007;39:857-64.
32. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-62.
33. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010;42:1118-25.
34. Anderson CA, Massey DC, Barrett JC, et al. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009;136:523-9.e3.
35. Baranathan V, Stanford MR, Vaughan RW, et al. The association of the PTPN22 620W polymorphism with Behcet's disease. Ann Rheum Dis 2007;66: 1531-3.
36. Gateva V, Sandling JK, Hom G, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009;41:1228-33.
37. Graham RR, Hom G, Ortmann W, et al. Review of recent genome-wide association scans in lupus. J Intern Med 2009;265:680-8.
38. Harley JB, Alarcon-Riquelme ME, Criswell LA, et al., International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN). Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008;40:204-10.
39. Serrano A, Marquez A, Mackie SL, et al. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis. Ann Rheum Dis 2013;72:1882-6.
40. Carmona FD, Mackie SL, Martin JE, et al. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. Am J Hum Genet 2015;96:565-80.
41. Hemminki K, Li X, Sundquist J, et al. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum 2009;60: 661-8.
42. Knight A, Sandin S, Askling J. Increased risk of autoimmune disease in families with Wegener's granulomatosis. J Rheumatol 2010;37:2553-8.
43. Segelmark M, Elzouki AN, Wieslander J, et al. The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 1995;48:844-50.
44. Sirota M, Schaub MA, Batzoglou S, et al. Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet 2009;5:e1000792.